Skip to main content
Back to Bills
FederalDid not become law (session ended)43rd Parliament, 1st Session

Bill S-216 explained in plain English

An Act to amend the Assisted Human Reproduction Act

Federal Parliament bill summary, status, timeline, sponsor, votes, and official sources.

At a glance

Jurisdiction
Federal Parliament
Legislature / Parliament
Parliament of Canada
Session
43rd Parliament, 1st Session
Bill number
Bill S-216
Full title
An Act to amend the Assisted Human Reproduction Act
Current status
Did not become law (session ended)
Latest event
At second reading in the Senate
Last updated
Mar 12, 2020

Official Parliament of Canada snapshot for 43rd Parliament, 1st Session. MP vote breakdowns appear when the House of Commons publishes a recorded division export for that bill. Senate and House stage details include official debate/sitting links when LEGISinfo publishes them.

Chamber
Parliament of Canada
Current Stage
At second reading in the Senate
Latest Activity
Mar 12, 2020
Plain-language explanation
In plain English (our explanation)

Our plain-language take, written for civic education.

Source: By PoliticalData.ca

AI-assisted, reviewed before publishing
Short Version

This bill amends the Assisted Human Reproduction Act to decriminalize certain payments related to sperm or ovum donation and surrogacy, and to allow for the purchase of other human reproductive materials.

What It Means

Bill S-216, also known as An Act to amend the Assisted Human Reproduction Act, proposes changes to the Assisted Human Reproduction Act. The bill aims to decriminalize payments for sperm or ovum donation and for surrogacy under certain conditions, and to allow for the purchase of other human reproductive materials. It also repeals certain provisions related to the prohibition of payments for sperm or ovum donation and for surrogacy arrangements.

What This Bill Does
  • It amends the Assisted Human Reproduction Act to permit payment for sperm or ovum donation and for surrogacy in specific circumstances.
  • It allows for the purchase of other human reproductive materials.
  • It removes certain prohibitions related to payment for sperm or ovum donation and surrogacy arrangements.
Who Is Affected
  • Individuals seeking to donate sperm or ova.
  • Individuals seeking to become surrogate mothers.
  • Individuals or couples seeking assisted reproduction services.
  • Entities involved in arranging or facilitating human reproduction.
  • Individuals or entities involved in the purchase or sale of human reproductive materials.
  • Regulated bodies under the Assisted Human Reproduction Act.
Rights, Duties, Or Obligations
  • The bill potentially creates new circumstances under which payments for sperm or ovum donation and surrogacy may be permissible, effectively altering existing prohibitions.
  • The bill clarifies conditions under which counseling or inducing individuals for sperm/ovum donation or surrogacy is prohibited (e.g., age, consent, coercion).
Important Dates
  • The Act comes into force 180 days after receiving royal assent.
Financial Or Tax Impacts
  • The bill decriminalizes payment for sperm or ovum donation and surrogacy in certain circumstances, which may have financial implications for individuals and service providers in this area. The specifics of these financial impacts are not detailed in the provided text.
Enforcement Or Penalties
  • The bill amends the Assisted Human Reproduction Act, which contains provisions for enforcement and penalties. While the bill itself does not detail new penalties, the changes to the Act could affect how existing enforcement mechanisms apply. Specific penalties related to the previous prohibitions are not elaborated upon in the provided text.
Uncertainties Or Limits
  • The bill refers to 'certain circumstances' for permitted payments without providing explicit details within the provided text. The full scope of these circumstances would likely be defined in regulations.
  • The specific details of 'other human reproductive material' that can be purchased are not defined in the provided text.
  • The nature of the expenditures for which reimbursement is permitted under the amended Section 12(1) of the Assisted Human Reproduction Act is limited to 'maintenance or transport of an in vitro embryo', with other reimbursement categories from the original Section 12(1) being removed.
  • The exact nature of the provisions repealed in Section 65(1)(e.1) is not specified in the provided text, making the full impact of its removal unclear without reference to the original Act.
Laws Or Regulations Affected
Assisted Human Reproduction Act
amends

Removes the prohibition on trade in the reproductive capabilities of women and men for commercial ends, and the exploitation of children, women, and men for commercial ends, by amending Section 2 to remove paragraph (f) which previously stated these were health and ethical concerns justifying prohibition. It also adds 'and' to the end of paragraph (e) which deals with non-discrimination in assisted reproduction procedures.

Source: Section 1 and Section 2(1) of the Bill

Assisted Human Reproduction Act
amends

Replaces Section 6 of the Act, which previously prohibited paying consideration to a female person to be a surrogate mother, offering to pay, or advertising such payments. The new Section 6, as described in the bill text, focuses on prohibitions against counseling or inducing a female to become a surrogate mother under certain conditions (under 21, incapable of consent, or coerced). The previous prohibition on payment is removed by implication through the replacement of the section.

Source: Section 2 of the Bill

Assisted Human Reproduction Act
amends

Replaces Subsection 7(1) of the Act, which previously prohibited purchasing, offering to purchase, or advertising the purchase of sperm or ova. The new Subsection 7(1) prohibits counseling or inducing a person to donate sperm or ova, or performing medical procedures to assist donation, if the person is under 18, incapable of consenting, or being coerced. Subsection 7(3) of the Act, which prohibited the purchase of human cells or genes for the purpose of creating a human being, is repealed.

Source: Section 3 of the Bill

Assisted Human Reproduction Act
amends

Replaces Subsection 12(1) of the Act. The original subsection prohibited reimbursement for expenditures related to sperm or ovum donation, maintenance or transport of an in vitro embryo, or surrogacy, except as allowed by regulations. The new subsection 12(1) prohibits reimbursement for expenditures incurred in the maintenance or transport of an in vitro embryo, except in accordance with regulations. Subsection 12(3) of the Act is repealed.

Source: Section 4 of the Bill

Assisted Human Reproduction Act
repeals

Repeals paragraph 65(1)(e.1) of the Act. The specific content of this repealed paragraph is not detailed in the provided text, but its repeal is part of the bill's amendments.

Source: Section 5 of the Bill

Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.

Official text

Parliamentary Process

Step 1
First reading
Feb 20, 2020
Completed

Bill S-216, aiming to amend the Assisted Human Reproduction Act, completed its first reading in the Senate on February 20, 2020, and was debated at second reading on March 12, 2020.

Introduction and first reading, Feb 20, 2020
End of stage activity, Feb 20, 2020
Chamber sittings
Introduction and first reading - Feb 20, 2020

The Senate of Canada proceeded with the first reading of Bill S-216, an Act to amend the Assisted Human Reproduction Act, during a sitting that also included various statements, question period exchanges, and debates on other matters.

Step 2
Second reading
Mar 12, 2020
Not completed

Bill S-216, concerning amendments to the Assisted Human Reproduction Act, reached its second reading stage in the Senate on March 12, 2020, where debate and a sponsor's speech took place.

Chamber sittings
Debate at second reading - Mar 12, 2020

The Senate sat on March 12, 2020, engaging in statements, tabling reports, question period on various topics including the coronavirus, and continuing debate on several bills, including Bill S-216 to amend the Assisted Human Reproduction Act.

In the Senate, Senator Lucie Moncion sponsored Bill S-216 to amend the Assisted Human Reproduction Act, advocating for the decriminalization of commercial surrogacy and gamete donation, while Senator Julie Miville-Dechêne raised concerns about the ethical implications, leading to an adjourned debate.

Step 3
Third reading
Not reached yet
Not reached

We don't have a plain-language summary for Third reading yet. The official source linked below is the full record.

Step 1
First reading
Not reached yet
Not reached

We don't have a plain-language summary for First reading yet. The official source linked below is the full record.

Step 2
Second reading
Not reached yet
Not reached

We don't have a plain-language summary for Second reading yet. The official source linked below is the full record.

Step 3
Consideration in committee
Not reached yet
Not reached

We don't have a plain-language summary for Consideration in committee yet. The official source linked below is the full record.

Step 4
Report stage
Not reached yet
Not reached

We don't have a plain-language summary for Report stage yet. The official source linked below is the full record.

Step 5
Third reading
Not reached yet
Not reached

We don't have a plain-language summary for Third reading yet. The official source linked below is the full record.

Debate and sitting links point to official parliamentary sources when LEGISinfo publishes them. Any plain-language discussion summaries should be generated from those official texts and reviewed before public display.

Vote Summary

No published recorded division

This bill is still active. We only show vote counts after the legislature publishes a recorded division.

Sponsor
Lucie Moncion
Senator | Independent Senators Group (ISG) | Ontario
Jurisdiction
Federal Parliament

No published representative vote breakdown

This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.

Official sources

Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.

How this data is sourced